|
1
|
Hsu YC, Lin JT, Chen TT, Wu MS and Wu CY:
Long-term risk of recurrent peptic ulcer bleeding in patients with
liver cirrhosis: a 10-year nationwide cohort study. Hepatology.
56:698–705. 2012.PubMed/NCBI
|
|
2
|
Li L, Yu C and Li Y: Endoscopic band
ligation versus pharmacological therapy for variceal bleeding in
cirrhosis: a meta-analysis. Can J Gastroenterol. 25:147–155.
2011.PubMed/NCBI
|
|
3
|
Qin T, Xia J, Ren H, Zhou H, Tang B and
Shao Z: Liver cirrhosis as a predisposing condition for
Legionnaires' disease: a report of four laboratory-confirmed cases
from China. J Med Microbiol. 61:1023–1028. 2012. View Article : Google Scholar
|
|
4
|
Wang SB, Wang JH, Chen J, Giri RK and Chen
MH: Natural history of liver cirrhosis in south China based on a
large cohort study in one center: a follow-up study for up to 5
years in 920 patients. Chin Med J (Engl). 125:2157–2162.
2012.PubMed/NCBI
|
|
5
|
Giannone FA, Baldassarre M, Domenicali M,
et al: Reversal of liver fibrosis by the antagonism of
endocannabinoid CB1 receptor in a rat model of CCl(4)-induced
advanced cirrhosis. Lab Invest. 92:384–395. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Madro A, Czechowska G, Slomka M, Celinski
K, Szymonik-Lesiuk S and Kurzepa J: The decrease of serum MMP-2
activity corresponds to alcoholic cirrhosis stage. Alcohol.
46:155–157. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wirkowska A and Paczek L: Liver fibrosis
and cirrhosis--selected cytokines, growth factors and proteins.
Part II Przegl Lek. 68:228–230. 2011.(In Polish).
|
|
8
|
Oliveira-Junior MC, Monteiro AS,
Leal-Junior EC, et al: Low-level laser therapy ameliorates
CCl(4)-induced liver cirrhosis in rats. Photochem Photobiol.
89:173–178. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee JK, Kim JH and Shin HK: Therapeutic
effects of the oriental herbal medicine Sho-saiko-to on liver
cirrhosis and carcinoma. Hepatol Res. 41:825–837. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao S, Yaqoob U, Das A, et al:
Neuropilin-1 promotes cirrhosis of the rodent and human liver by
enhancing PDGF/TGF-beta signaling in hepatic stellate cells. J Clin
Invest. 120:2379–2394. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iizuka M, Ogawa T, Enomoto M, et al:
Induction of microRNA-214-5p in human and rodent liver fibrosis.
Fibrogenesis Tissue Repair. 5:122012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He Y, Huang C, Sun X, Long XR, Lv XW and
Li J: MicroRNA-146a modulates TGF-beta1-induced hepatic stellate
cell proliferation by targeting SMAD4. Cell Signal. 24:1923–1930.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Noetel A, Kwiecinski M, Elfimova N, Huang
J and Odenthal M: microRNA are central players in anti- and
profibrotic gene regulation during liver fibrosis. Front Physiol.
3:492012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ogawa T, Enomoto M, Fujii H, et al:
MicroRNA-221/222 upregulation indicates the activation of stellate
cells and the progression of liver fibrosis. Gut. 61:1600–1609.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dueck A, Ziegler C, Eichner A, Berezikov E
and Meister G: microRNAs associated with the different human
Argonaute proteins. Nucleic Acids Res. 40:9850–9862. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gurtan AM, Lu V, Bhutkar A and Sharp PA:
In vivo structure-function analysis of human Dicer reveals
directional processing of precursor miRNAs. RNA. 18:1116–1122.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Andersson T, Rahman S, Sansom SN, et al:
Reversible block of mouse neural stem cell differentiation in the
absence of dicer and microRNAs. PLoS One. 5:e134532010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chiosea S, Jelezcova E, Chandran U, et al:
Up-regulation of dicer, a component of the MicroRNA machinery, in
prostate adenocarcinoma. Am J Pathol. 169:1812–1820. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vaksman O, Hetland TE, Trope' CG, Reich R
and Davidson B: Argonaute, Dicer, and Drosha are up-regulated along
tumor progression in serous ovarian carcinoma. Hum Pathol.
43:2062–2069. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang X, Cairns M, Rose B, et al:
Alterations in miRNA processing and expression in pleomorphic
adenomas of the salivary gland. Int J Cancer. 124:2855–2863. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martin MG, Payton JE and Link DC: Dicer
and outcomes in patients with acute myeloid leukemia (AML). Leuk
Res. 33:e1272009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu JF, Shen W, Liu NZ, et al:
Down-regulation of Dicer in hepatocellular carcinoma. Med Oncol.
28:804–809. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lakner AM, Steuerwald NM, Walling TL, et
al: Inhibitory effects of microRNA 19b in hepatic stellate
cell-mediated fibrogenesis. Hepatology. 56:300–310. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Uyama N, Iimuro Y, Kawada N, et al:
Fascin, a novel marker of human hepatic stellate cells, may
regulate their proliferation, migration, and collagen gene
expression through the FAK-PI3K-Akt pathway. Lab Invest. 92:57–71.
2012. View Article : Google Scholar
|
|
25
|
Ramachandran P and Iredale JP: Liver
fibrosis: a bidirectional model of fibrogenesis and resolution.
QJM. 105:813–817. 2012. View Article : Google Scholar
|
|
26
|
Takashima M, Parsons CJ, Ikejima K,
Watanabe S, White ES and Rippe RA: The tumor suppressor protein
PTEN inhibits rat hepatic stellate cell activation. J
Gastroenterol. 44:847–855. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bian EB, Huang C, Ma TT, et al:
DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell
activation and liver fibrogenesis in rats. Toxicol Appl Pharmacol.
264:13–22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tao H, Huang C, Yang JJ, et al: MeCP2
controls the expression of RASAL1 in the hepatic fibrosis in rats.
Toxicology. 290:327–333. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li WQ, Chen C, Xu MD, et al: The
rno-miR-34 family is upregulated and targets ACSL1 in
dimethylnitrosamine-induced hepatic fibrosis in rats. FEBS J.
278:1522–1532. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang B, Li W, Guo K, Xiao Y, Wang Y and
Fan J: miR-181b promotes hepatic stellate cells proliferation by
targeting p27 and is elevated in the serum of cirrhosis patients.
Biochem Biophys Res Commun. 421:4–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
